Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cervical Cancer- Epidemiology Forecast to 2023

Posted on: 30 Nov 17
Cervical Cancer- Epidemiology Forecast to 2023 DelveInsight's "Cervical Cancer- Epidemiology Insights-2023" Reports provides an overview of the disease and the global historical and forecasted epidemiological data of the Cervical Cancer for the 7 major markets- United States, EU5(Germany, France, Italy, Spain and United Kingdom) and Japan for 2013-2023.

PR Newswire

LONDON, Nov. 30, 2017

LONDON, Nov. 30, 2017 /PRNewswire/ -- Download the full report:

According to Publisher, the incidence rate for Cervical Cancer and its subtypes from 2015 to 2023 will remain the same. However, the number of incident cases is expected to increase due to the increase in the total female population.
Cervical Cancer occurred due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus.

Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Key Coverage and Benefits
Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

The Report covers the detailed global historical and forecasted epidemiological data covering 7MM from 2013-2023.

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

View original content:

SOURCE ReportBuyer

PR Newswire

Last updated on: 30/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.